Abstract
TransCelerate has created an initiative to facilitate the industry’s movement toward optimal use of electronic data sources for clinical research. Although guidance and standards have been in place for some time, gaps remain. Consequently, transcription among electronic systems continues to be the norm. In the initial phase of the eSource Initiative, TransCelerate is developing a thorough understanding of the current landscape. As a preliminary step in this process, the TransCelerate eSource Initiative published Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape Part I, which provided insight into sponsor company eSource activities and the environment affecting eSource adoption based on input from TransCelerate member companies, standards organizations, and regulatory authorities. For Part II (this article), TransCelerate surveyed technology companies, including CROs providing technology, to better understand capabilities available today, plans for eSource, and perceived barriers to greater adoption. This information is a vital input that will help shape upcoming TransCelerate proposals for best practices for industry utilization of electronic data collection tools and methods. It is clear from the survey results that the technologies needed to support the various eSource modalities are mature. However, the approach to implementing eSource is fragmented. Greater collaboration is needed not only within the pharmaceutical industry but across industries that include health care and technology. The industry must reach common understandings about novel endpoints, data standards, system validation, and related issues. While technology in itself is not a significant barrier to eSource implementation, interoperability among systems is an enormous challenge to establishing a complete end-to-end electronic health care and research ecosystem. The TransCelerate eSource Initiative will continue to evaluate the technology, regulatory environment, data standards, and health care landscape to support the goal of improving global clinical science and global clinical trial execution. Forthcoming publications will focus on future vision and demonstration projects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kellar E, Bornstein SM, Caban A. Optimizing the use of electronic data sources in clinical trials: the landscape, part 1. Therapeutic Innovation & Regulatory Science. 2016;50:682–696.
US Food and Drug Administration. Guidance for industry: electronic source data in clinical investigations. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm328691.pdf. Accessed July 2016.
IEEE Standards Glossary. https://www.ieee.org/education_careers/education/standards/standards_glossary.html. Accessed April 2017.
Sherman RE. What we mean when we talk about EvGen part I: laying the foundation for a national system for evidence generation. http://blogs.fda.gov/fdavoice/index.php/2016/04/what-we-mean-when-we-talk-about-evgen-part-i-laying-the-foundation-for-a-national-system-for-evidence-generation/. Accessed January 2017.
HL7 International. Welcome to the Argonaut project. http://argonautwiki.hl7.org/index.php?title=Main_Page. Accessed January 2017.
Laird-Maddox M, Mitchell SB, Hoffman M. Integrating research data capture into the electronic health record workflow: real-world experience to advance innovation. http://library.ahima.org/doc?oid=300741#.WFvnC1dzHA4. Accessed January 2017.
Clinical Ink white paper. eSource: reducing site workload for better, faster, safer clinical trials. http://www.clinicalink.com/wp-content/uploads/2015/10/Site-Impact-White-Paper_FINAL_101915.pdf. Published October 2015. Accessed April 2017.
Health Information and Management Systems Society (HIMSS). Definitions of health. http://www.himss.org/definitions-mhealth. Accessed January 2017.
Henderson L. The use of mHealth in clinical trials. http://www.appliedclinicaltrialsonline.com/use-mhealth-clinical-trials. Accessed January 2017.
Chan M, Estève D, Fourniols JY, Escriba C, Campo E. Smart wearable systems: current status and future challenges. Artif Intell Med. 2012;56:137–156.
Maddox T. The dark side of wearables: how they’re secretly jeopardizing your security and privacy. http://www.techrepublic.com/article/the-dark-side-of-wearables-how-theyre-secretly-jeopardizing-your-security-and-privacy/. Accessed January 2016.
Ibara M. Interoperability…even with the regulators. https://www.linkedin.com/pulse/interoperabilityeven-regulators-michael-ibara. Accessed December 2016.
Health Level Seven International. http://www.hl7.org/. Accessed December 2016.
US Food and Drug Administration. Source data capture from electronic health records (EHRs): Using standardized clinical research data. https://www.fda.gov/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/ucm464653.htm. Accessed April 2017.
Manos D., CIOs tell ONC: It’s time to let the EHR market innovate to drive interoperability. http://m.healthcareitnews.com/news/cios-tell-onc-its-time-let-EHR-market-innovate-drive-interoperability?platform=hootsuite. Accessed December 2016.
Slabodkin G. Obama signs 21st Century Cures Act into law. http://www.healthdatamanagement.com/news/obama-signs-21st-century-cures-act-into-law. Accessed January 2017.
Creswell J. Doctors find barriers to sharing digital medical records. http://www.nytimes.com/2014/10/01/business/digital-medical-records-become-common-but-sharing-remains-challenging.html?_r=1. Accessed December 2016.
Hirsch MD. Canadian clinicians report “positive” experience with interoperability. FierceHealthcare. http://www.fiercehealthcare.com/it/canadian-clinicians-report-positive-experience-interoperability. Accessed December 2016.
King L, Agarwal S, Bhardwaj S, et al. eSource in clinical Research: a data management perspective on the use of mobile health technology. The Society for Clinical Data Management White Paper. http://scdm.org/wp-content/uploads/2016/09/SCDM-Mobile-Health-White-Paper.pdf. Published September 2016. Accessed December 2016.
Clinical Data Interchange Standards Consortium (CDISC). Strategic goals 2015-2017. http://cdisc.org/strategies-and-goals. Accessed January 2017.
Branzell R. With growing momentum in the private sector to tackle the issue, is this the year of universal, positive patient identification? http://www.healthcare-informatics.com/article/top-ten-tech-trend-national-patient-id-movement. Accessed January 2017.
Agency for Healthcare Research and Quality. LOINC. https://healthit.ahrq.gov/key-topics/loinc. Accessed January 2017.
Digital Imaging and Communications in Medicine (DICOM). http://dicom.nema.org/. Accessed January 2017.
Robbins DA, Curro FA, Fox CH. Defining patient-centricity opportunities, challenges, and implications for clinical care and research. Therapeutic Innovation & Regulatory Science. 2013;47:349–355.
Owens P, Atkins N, O’Brien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension. 1999;34:267–272.
Coons SJ, Eremenco S, Lundy JJ, O’Donohoe P, O’Gorman H, Malizia W. Capturing patient-reported outcome (PRO) data electronically: the past, present, and promise of ePRO measurement in clinical trials. Patient. 2015;8:301–309.
Byrom B, Lee J, Dennis K, Noble M, McCarthy M, Muehlhausen W. Bring your own device for trial outcome assessment. Appl Clin Trials. http://www.appliedclinicaltrialsonline.com/bring-your-own-device-trial-outcome-assessment. Accessed January 2017.
SMART Health IT. https://smarthealthit.org/. Accessed April 2017.
Pennic J. HIT Consultant. Medidata, validic partner to transform clinical trials using patient-generated data. http://hitconsultant.net/2015/07/21/medidata-validic-partner-to-transform-clinical-trials/. Accessed January 2017.
Entra Health. Entra Health sharpens market focus in clinical research. http://entrahealth.com/entra-health-sharpens-market-focus-in-clinical-research-2/. Accessed January 2017.
Symantec. 2015 Internet security threat report, volume 20. https://www.symantec.com/content/en/us/enterprise/other_resources/21347933_GA_RPT-internet-security-threat-report-volume-20-2015.pdf. Accessed January 2017.
Beckland R. How wearable technologies can enhance subject recruitment for clinical trials. Healthcare IT News. http://www.healthcareitnews.com/news/how-wearable-technologies-can-enhance-subject-recruitment-clinical-trials. Accessed December 2016.
Maddox T. The dark side of wearables: How they’re secretly jeopardizing your security and privacy. TechRepublic. http://www.techrepublic.com/article/the-dark-side-of-wearables-how-theyre-secretly-jeopardizing-your-security-and-privacy/. Accessed December 2016.
Sherman RE, Califf RM. What we mean when we talk about EvGen part II: building out a national system for evidence generation. http://blogs.fda.gov/fdavoice/?s=evgen. Accessed January 2017.
Blueprint for breakthrough: exploring the utility of real world evidence (RWE). Friends of Cancer Research, Alexandria Summit, June 2016. http://www.focr.org/sites/default/files/pdf/RWE%20-%20Project%20PRE-MEETING%20DRAFT.pdf.
Flatiron.com. The Center for Cancer and Blood Disorders selects Flatiron Health OncoEMR to support its transition to value-based care. https://www.flatiron.com/press/fda-research. Accessed April 2017.
Blumenthal D, Tavenner M. The “meaningful use” regulation for electronic health records. N Engl J Med. 2010;363:501–504.
Jha AK. Meaningful use of electronic health records: the road ahead. JAMA. 2010;304:1709–1710.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Kellar, E., Bornstein, S., Caban, A. et al. Optimizing the Use of Electronic Data Sources in Clinical Trials: The Technology Landscape. Ther Innov Regul Sci 51, 551–567 (2017). https://doi.org/10.1177/2168479017718875
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479017718875